Your browser doesn't support javascript.
loading
Urinary lysophopholipids are increased in diabetic patients with nephropathy.
Saulnier-Blache, Jean-Sébastien; Feigerlova, Eva; Halimi, Jean Michel; Gourdy, Pierre; Roussel, Ronan; Guerci, Bruno; Dupuy, Aude; Bertrand-Michel, Justine; Bascands, Jean-Loup; Hadjadj, Samy; Schanstra, Joost P.
Afiliação
  • Saulnier-Blache JS; Institut National de la Santé et de la Recherche Médicale (INSERM), U1048, Institut of Cardiovascular and Metabolic Disease, Toulouse, France; Université Toulouse III Paul-Sabatier, Toulouse, France. Electronic address: jean-sebastien.saulnier-blache@inserm.fr.
  • Feigerlova E; CHU de Poitiers, Service d'Endocrinologie, Pole DUNE, 86021, Poitiers, France; Université de Poitiers, UFR Médecine Pharmacie, 86021, Poitiers, France; Inserm, CIC 1402 & U1082, 86021, Poitiers, France.
  • Halimi JM; CHU de Tours, Service Néphrologie-immunologie clinique, 37000, Tours, France; Université François-Rabelais, EA4245, Inserm, 37000, Tours, France.
  • Gourdy P; Institut National de la Santé et de la Recherche Médicale (INSERM), U1048, Institut of Cardiovascular and Metabolic Disease, Toulouse, France; Université Toulouse III Paul-Sabatier, Toulouse, France; CHU de Toulouse, Service de Diabétologie, Maladies Métaboliques et Nutrition, 31059, Toulouse, Franc
  • Roussel R; Université Paris Diderot, Sorbonne Paris Cité, 75013, Paris, France; Inserm, UMRS1138, Centre de Recherche des Cordeliers, 75006, Paris, France, AP-HP; Hôpital Bichat, Diabétologie, Endocrinologie Nutrition, DHU FIRE, 75018, Paris, France.
  • Guerci B; Université de Lorraine & CHRU de Nancy, Diabétologie, Maladies Métaboliques et Nutrition, 54511, Vandoeuvre lès Nancy.
  • Dupuy A; Institut National de la Santé et de la Recherche Médicale (INSERM), U1048, Institut of Cardiovascular and Metabolic Disease, Toulouse, France; Metatoul-Lipidomic core facility, MetaboHub, Institut National de la Santé et de la Recherche Médicale (INSERM), U1048, Institut of Cardiovascular and Metabo
  • Bertrand-Michel J; Institut National de la Santé et de la Recherche Médicale (INSERM), U1048, Institut of Cardiovascular and Metabolic Disease, Toulouse, France; Metatoul-Lipidomic core facility, MetaboHub, Institut National de la Santé et de la Recherche Médicale (INSERM), U1048, Institut of Cardiovascular and Metabo
  • Bascands JL; Institut National de la Santé et de la Recherche Médicale (INSERM), U1188 - Université de La Réunion, France.
  • Hadjadj S; CHU de Poitiers, Service d'Endocrinologie, Pole DUNE, 86021, Poitiers, France; Université de Poitiers, UFR Médecine Pharmacie, 86021, Poitiers, France; Inserm, CIC 1402 & U1082, 86021, Poitiers, France.
  • Schanstra JP; Institut National de la Santé et de la Recherche Médicale (INSERM), U1048, Institut of Cardiovascular and Metabolic Disease, Toulouse, France; Université Toulouse III Paul-Sabatier, Toulouse, France. Electronic address: joost-peter.schanstra@inserm.fr.
J Diabetes Complications ; 31(7): 1103-1108, 2017 Jul.
Article em En | MEDLINE | ID: mdl-28506691
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lisofosfolipídeos / Lisofosfatidilcolinas / Regulação para Cima / Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Insuficiência Renal / Rim Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lisofosfolipídeos / Lisofosfatidilcolinas / Regulação para Cima / Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Insuficiência Renal / Rim Idioma: En Ano de publicação: 2017 Tipo de documento: Article